Use With Statin Therapy
See how…niacin complements statin therapy for heart health
Niacin has been shown in studies to work with a type of cholesterol-lowering agent called statins to help support heart health.
SLO-NIACIN® Tablets plus LIPITOR® support heart health
- With proper monitoring and dosing by a healthcare professional, SLO-NIACIN® Tablets taken along with LIPITOR® (atorvastatin calcium) were shown to have a greater effect on high-density lipoprotein (HDL) cholesterol, or good cholesterol, than taking LIPITOR® alone
| SLIM study* | Increased good cholesterol (HDL) | Decreased bad cholesterol (LDL) | Decreased triglycerides |
|---|---|---|---|
| LIPITOR® (ALONE) | ↑ 6%† | ↓ 36%† | ↓ 26% |
| SLO-NIACIN® TABLETS (ALONE) | ↑ 8% | ↓ 12%† | ↓ 15%† |
| SLO-NIACIN® TABLETS + LIPITOR® | ↑ 10%† | ↓ 43%† | ↓ 33%† |
Niacin plus ZOCOR® support heart health
- With proper monitoring and dosing by a healthcare professional, niacin (SLO-NIACIN® Tablets or immediate-release niacin) taken along with ZOCOR® (simvastatin) were shown to have a positive effect on HDL as well as heart health
| HATS trial‡ | Increased good cholesterol (HDL) | Decreased bad cholesterol (LDL) | Decreased triglycerides | Decreased total cholesterol |
|---|---|---|---|---|
| NIACIN + ZOCOR® | ↑ 26%† | ↓ 42%† | ↓ 36%† | ↓ 31%† |

- Niacin (SLO-NIACIN® Tablets or immediate-release niacin) taken along with ZOCOR® reduced the risk of a cardiovascular event, such as a heart attack, by 90% compared to placebo
- Niacin (SLO-NIACIN® Tablets or immediate-release niacin) taken along with ZOCOR® helped stop progression of stenosis (arteries closing)
Please remember that people already taking cholesterol-lowering drugs should contact a healthcare professional before taking niacin because of possible side effects and interactions.
Talk to your healthcare professional to find out if SLO-NIACIN® Tablets can help you.
Next: For information on how to take SLO-NIACIN® Tablets
![]()
*A 6-month randomized, open-label trial of 42 patients with LDL >130 mg/dL and HDL <45 mg/dL for men (<55 mg/dL for women) who received 3 months of atorvastatin 10 mg/day or incremental doses of SLO-NIACIN® Tablets to 1500 mg/day followed by 3 months of combined treatment.
†Statistically significant P value compared to baseline.
‡A 3-year, double-blind, randomized trial of 160 patients with coronary disease, low HDL, and normal LDL, were assigned to one of four regimens: simvastatin (13 mg +/- 6 mg) plus niacin (2400 mg +/- 2000 mg), antioxidants, simvastatin-niacin plus antioxidants, or placebo.
LIPITOR is a registered trademark of Pfizer, Inc.
ZOCOR is a registered trademark of Merck & Co, Inc.







